VINCENT RICHARD G
Insider CIK 1269341 · ONCT Chief Financial Officer · FBRX Director · SRNE See Remarks, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 31,000 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 18,353 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 2,000 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 18,353 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 31,000 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 2,000 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2026-05-29 | 2026-06-02 | 18,353 | — | $0 | 18,353 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2025-03-20 | 2025-03-21 | 31,000 | — | $0 | 31,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2024-09-17 | 2024-09-19 | 2,000 | — | $0 | 2,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2024-02-14 | 2024-02-15 | 14,200 | — | $0 | 14,200 | SEC↗ |
| ONCT Oncternal Therapeutics, In | F Tax w/h | 2024-01-03 | 2024-01-05 | 8,868 | $0.50 | $4.4K | 140,922 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 35,120 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 75,000 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 210,000 | — | $0 | 210,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 28,750 | — | $0 | 28,750 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 280,000 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 109,597 | — | $0 | 109,597 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 280,000 | — | $0 | 280,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 35,120 | — | $0 | 35,120 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 210,000 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 28,750 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 109,579 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | F Tax w/h | 2023-07-03 | 2023-07-05 | 7,069 | $0.36 | $2.5K | 149,790 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2023-04-13 | 2023-04-14 | 30,000 | $0.30 | $9.0K | 156,859 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-02-21 | 2023-02-23 | 210,000 | — | $0 | 210,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | F Tax w/h | 2023-01-03 | 2023-01-05 | 4,428 | $1.02 | $4.5K | 126,859 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2022-07-28 | 2022-08-01 | 28,750 | — | $0 | 28,750 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award | 2022-07-28 | 2022-08-01 | 43,125 | — | $0 | 131,287 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2022-03-28 | 2022-03-28 | 2,500 | $1.40 | $3.5K | 88,162 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2022-03-25 | 2022-03-28 | 356 | $1.45 | $516 | 83,521 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2022-03-25 | 2022-03-28 | 5 | $1.48 | $7 | 83,526 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2022-03-25 | 2022-03-28 | 2,136 | $1.49 | $3.2K | 85,662 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2022-03-24 | 2022-03-28 | 3 | $1.45 | $4 | 83,165 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2022-01-28 | 2022-01-31 | 2,500 | $1.65 | $4.1K | 83,162 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2022-01-27 | 2022-01-31 | 5,000 | $1.80 | $9.0K | 75,662 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2022-01-27 | 2022-01-31 | 5,000 | $1.70 | $8.5K | 80,662 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2022-01-20 | 2022-01-24 | 109,579 | — | $0 | 109,579 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award | 2022-01-03 | 2022-01-05 | 29,867 | — | $0 | 70,662 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2021-02-11 | 2021-02-16 | 280,000 | — | $0 | 280,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-03-17 | 2020-07-31 | 35,120 | — | $0 | 35,120 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-03-17 | 2020-03-18 | 35,120 | — | $0 | 35,120 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2019-09-12 | 2020-07-31 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2019-09-12 | 2019-09-16 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ONCT GTX INC /DE/ | A Award deriv | 2019-06-07 | 2019-06-11 | 281 | — | $0 | 281 | SEC↗ |
| ONCT GTX INC /DE/ | A Award deriv | 2019-06-07 | 2019-06-11 | 73,385 | — | $0 | 73,385 | SEC↗ |
| ONCT GTX INC /DE/ | A Award | 2019-06-07 | 2019-06-11 | 4,526 | — | $0 | 4,526 | SEC↗ |
| ONCT GTX INC /DE/ | A Award | 2019-06-07 | 2019-06-11 | 42,628 | — | $0 | 40,794 | SEC↗ |
| ONCT GTX INC /DE/ | A Award | 2019-06-07 | 2019-06-11 | 1,834 | — | $0 | 1,834 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2014-10-07 | 2014-10-09 | 50,000 | — | $0 | 270,000 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2013-10-29 | 2013-10-31 | 100,000 | — | $0 | 220,000 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | D To issuer deriv | 2012-09-30 | 2012-10-19 | 725,000 | — | $0 | 2,275,000 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | D To issuer deriv | 2012-09-30 | 2012-10-19 | 725,000 | — | $0 | 2,275,000 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2012-09-22 | 2012-09-25 | 3,000,000 | — | $0 | 3,000,000 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2012-02-06 | 2012-02-07 | 125,000 | — | $0 | 125,000 | SEC↗ |